V. Craig Jordan, Ph.D., professor of Breast Medical Oncology, has been elected to the National Academy of Medicine for his discovery of selective estrogen receptor modulators (SERMs), a class of drugs with far-reaching impact on women’s health.
Jordan’s findings include application of the original SERM, the estrogen-blocking drug tamoxifen, to the treatment and prevention of breast cancer, and discovery that raloxifene prevents...
Pediatric cancer patients who eat a healthy diet and exercise regularly may experience fewer cancer treatment side effects later in life,...
Patients with stage zero breast cancer, also known as ductal carcinoma in situ, who undergo breast-conserving surgery that results in narrow...
Recently approved targeted and immunotherapy drugs are helping patients diagnosed with follicular lymphoma live longer. Knowing the available treatment options can help physicians recommend the most appropriate treatment for their patients with newly diagnosed or relapsed or refractory follicular lymphoma.
For nearly 40 years, chemotherapy was the standard of care for follicular lymphoma, which is the second most common non-Hodgkin...
When Craig Bunk began experiencing severe abdominal pain, blood loss and fatigue, his family doctor thought a stomach ulcer was to blame....
Cancer is the second leading cause of death in the U.S., and will claim the lives of an estimated 600,920 in this country in 2017, according...
Practicing Tibetan yoga twice a week may reduce sleep disturbances and improve sleep quality for breast cancer patients receiving chemotherapy...
Despite significant advances in lung cancer treatment, new approaches for early detection and prevention remain limited because the earliest...